Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways

Circulation Research
Malcolm CampbellElisabeth R Trimble

Abstract

Atheroma formation involves the movement of vascular smooth muscle cells (VSMC) into the subendothelial space. The aim of this study was to determine the involvement of PI3K and MAPK pathways and the importance of cross-talk between these pathways, in glucose-potentiated VSMC chemotaxis to serum factors. VSMC chemotaxis occurred in a serum gradient in 25 mmol/L glucose (but not in 5 mmol/L glucose) in association with increased phosphorylation (activation) of Akt and ERK1/2 in PI3K and MAPK pathways, respectively. Inhibitors of these pathways blocked chemotaxis, as did an mTOR inhibitor. VSMC expressed all class IA PI3K isoforms, but microinjection experiments demonstrated that only the p110beta isoform was involved in chemotaxis. ERK1/2 phosphorylation was reduced not only by MAPK pathway inhibitors but also by PI3K and mTOR inhibitors; when PI3K was inhibited, ERK phosphorylation could be induced by microinjected activated Akt, indicating important cross-talk between the PI3K and ERK1/2 pathways. Glucose-potentiated phosphorylation of molecules in the p38 and JNK MAPK pathways inhibited these pathways but did not affect chemotaxis. The statin, mevinolin, blocked chemotaxis through its effects on the MAPK pathway. Mevinolin-in...Continue Reading

References

Feb 1, 1990·Nature·J L Goldstein, M S Brown
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·B VanhaesebroeckM D Waterfield
Oct 19, 1999·Molecular and Cellular Biology·M M HillS L Macaulay
Nov 13, 1999·Nature Cell Biology·B VanhaesebroeckA J Ridley
Sep 23, 2000·American Journal of Physiology. Endocrinology and Metabolism·W LiuW L Lowe
Jun 8, 2001·Annual Review of Biochemistry·B VanhaesebroeckM D Waterfield
Mar 30, 2002·Cardiovascular Research·Ulrich LaufsGeorg Nickenig
Jun 8, 2002·Biochemical and Biophysical Research Communications·K KingsleyG E Plopper
Jan 7, 2003·Neurochemical Research·Khaldoun AlmhannaLiliana N Berti-Mattera
Mar 13, 2003·Kidney International·Zhong-Gao XuShin-Wook Kang
Apr 8, 2003·Journal of the American College of Cardiology·Antonio M Gotto
May 14, 2003·Transplantation Proceedings·A R Marks
Jun 5, 2003·American Journal of Physiology. Endocrinology and Metabolism·S McGinnC A Pollock
Jul 15, 2003·Journal of Cellular Biochemistry·Jae J Song, Yong J Lee
Nov 5, 2003·Gene·Shen-Hsi YangAlan J Whitmarsh

❮ Previous
Next ❯

Citations

Mar 5, 2013·Cancer Chemotherapy and Pharmacology·Dipti K PawaskarWilliam J Jusko
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
May 29, 2009·Clinical and Experimental Pharmacology & Physiology·Xiao-Ping YangJun Ren
Dec 17, 2009·Journal of Experimental & Clinical Cancer Research : CR·Juanjuan LiuMasao Iwamori
Oct 12, 2012·The AAPS Journal·Dipti K PawaskarWilliam J Jusko
Mar 26, 2014·Molecular and Cellular Endocrinology·Milan ObradovicEsma R Isenovic
Dec 29, 2009·Journal of Molecular and Cellular Cardiology·Magda Descorbeth, Madhu B Anand-Srivastava
Jun 25, 2008·Journal of Molecular and Cellular Cardiology·Claire L Allen, Ulvi Bayraktutan
Jun 23, 2007·Medical Hypotheses·Bruce G Charlton
Sep 12, 2006·Biochemical and Biophysical Research Communications·Erik B FriedrichGeorg Nickenig
Nov 1, 2008·Human Pathology·Perumal VivekanandanMichael Torbenson
Feb 28, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ebubekir DiricanAyşe Özer
Aug 8, 2014·Journal of Clinical Pathology·Farnaz Bahrami-BDavid L Morris
Sep 23, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Kuei-Chuan ChanChien-Ning Huang
Feb 8, 2005·Journal of Vascular Surgery·William J TanskiMark G Davies
Jul 6, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Jing ShenShen-Jiang Hu
Jun 22, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Nasser Al-ShantiClaire E Stewart
May 8, 2018·International Journal of Molecular Sciences·Hozo MatsuokaHideki Yoshikawa
Dec 21, 2005·Journal of Leukocyte Biology·William G TharpMark C Poznansky
Feb 11, 2005·The Journal of Biological Chemistry·Zachary T Kneass, Richard B Marchase
Nov 17, 2005·The Journal of Biological Chemistry·Hideko HayashiEisuke Nishida
Jul 7, 2010·Expert Review of Cardiovascular Therapy·Gerald H Tomkin
Jul 3, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Abolfazl AkbariShahram Agah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.